Alterations in the translocation of the intestinal microbiota appear to be associated with L-FABP and I-FABP, which are recognized early serological markers of intestinal epithelial damage in MASLD [24]. The gene discussed is FABP2; the disease is metabolic dysfunction-associated steatotic liver disease.